WHO ICTRP trial

Hypotensive effects of Umezu polyphenols among community-dwelling hypertensive…

JPRN-UMIN000029394 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000029394
Public title Hypotensive effects of Umezu polyphenols among community-dwelling hypertensive patients not requiring medication
Scientific title Hypotensive effects of Umezu polyphenols among community-dwelling hypertensive patients not requiring medication - Hypotensive effects of Umezu polyphenols
Primary sponsor Wakayama Medical University
Secondary sponsors Kindai University Wakayama Industry Promotion Foundation
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not selected
Countries Japan
Conditions Hypertension
Interventions Four capsules containing Umezu polyphenols (200 mg per capsule) daily for 12 weeks, followed by 2 weeks of wash-out period and 12 months of follow-up period with mail surveys every 3 months. Four placebo capsules daily for 12 weeks…
Registration date Mar 10, 2017
Target size 100
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations